-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - Layout 1
Background
Almost 75 million American adults—
approximately one-third—have
hypertension. The prevalence of
hypertension increases with advancing age
such that more than half of people 55 to 74
years old and approximately three-fourths
of those age 75 years and older are
affected. In addition to being the pr…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy
Evidence-based Practice Center Systematic Review Protocol
Project Title: Postpartum Care for Women Up to One Year After Pregnancy
Initial Publication Date: February 24, 2022
Amendment Date: April 25, 2022
(Amendments Details-see Section VI…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
January 01, 2013 - 1
Comparative Effectiveness Review
Number 99
Outpatient Case Management for Adults With
Medical Illness and Complex Care Needs
Executive Summary
Background
Chronic diseases are the leading cause
of illness, disability, and death in the
United States.1 Providing medical care
for chronic illness is often compl…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (…
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is
part of AHRQ’s Effective Health Care program. It is a collaborative network of research
centers that support the rapid development o…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-users-amended-protocol.pdf
June 21, 2019 - Can Physical Activity Improve the Health of Wheelchair Users? Amended Protocol
Evidence-based Practice Center Systematic Review Protocol
Project Title: Can Physical Activity Improve the Health of Wheelchair Users?
A Systematic Review
Initial publication date: April 12, 2019
Amendment Date: June 21, 2019…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - 1
Comparative Effectiveness Review
Number 105
Interventions To Improve Cardiovascular Risk
Factors in People With Serious Mental Illness
Executive Summary
Background
Serious mental illness (SMI) is
defined generally as a major mental
or behavioral disorder, causing
substantial impairment in multiple areas …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - NCEP-ATP III
LDL-c target, LDL-c, HDL-c, and
TC:HDL-c ratio
• Non–HDL-c and triglycerides in a
diabetic … Fenofibrate, simvastatin and their combination in
the management
of dyslipidaemia in type 2 diabetic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - KQ1_IgG Duration_n=3
Observational studies examining IgG Duration
Author Year Title PMID Link/URL Country Study Design Length of follow-up (Months) Population category Population Description Data Source Study Period Inclusion criteria Exclusion criteria Total N Age: Mean (SD) years or Median (IQR) Race stratifi…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-tables-e1-4.xlsx
January 01, 2025 - mg/day Placebo NR NA NA NA NA 16 Short Industry Low
39720705 Seevathee, 2024 RCT No No Thailand NPP Diabetic … NA NA NA NA 12 Short University, government Moderate
19808912 Selvarajah, 2010 RCT No No Europe NPP Diabetic … NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA
Seevathee, 2024 None Moderate NPP Diabetic … NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR
Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire
Toth, 2012 None Low NPP Diabetic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
January 01, 2011 - Effective Health Care
Topic Number: 0404
Document Completion Date: 08-27-12
1
Prevention of Contrast-Induced Nephropathy
Nomination Summary Document
Results of Topic Selection Process & Next Steps
Prevention of contrast-induced nephropathy will go forward for refinement as a systematic revi…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
April 18, 2012 - Evidence-based Practice Center Systematic Review Protocol
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Strategies To Improve Cardiovascular Risk Factors in People With Serious
Mental Illness: A Comparative Effectiveness Review
Amendment Date(s):
Amendment 1 – January 20, 20…
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
October 01, 2021 - Comparative Effectiveness Review No. 241_Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury
Comparative Effectiveness Review
Number 241
Physical Activity and the Health of Wheelchair
Users: A Systematic Review in Multiple Scle…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - CI: 0.12,
72.49
Metabolism and
nutrition disorders:
1/710, 3/701
RR = 0.43; CI: 0.03,
3.17
Diabetic … ketoacidosis:
1/710, 1/701
RR = 0.99; CI:0.06,
15.76
Diabetic metabolic
decompensation:
0/710 … /526
RR = 0.34; CI: 0.01,
8.23
Respiratory failure:
0/523, 1/526
RR = 0.34; CI: 0.01,
8.23
Diabetic … Schizophrenia: 1/1627,
0/1643
RR = 3.03, CI: 0.12,
74.27
Mania: 0/1627, 1/1643
RR = 0.34; CI: 0.01,
8.26
Diabetic … 0.01,
3.98
Metabolism and
nutrition disorders
Acidosis: 1/295, 0/143
RR = 1.46; CI: 0.06,
35.49
Diabetic
-
effectivehealthcare.ahrq.gov/sites/default/files/lessons-presentation.pdf
January 01, 2013 - Community-Based Participatory Research Slides Text Version
Community-Based Participat…
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
March 01, 2021 - Disposition of Comments: Technical Brief No. 38_Automated Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes
Source: https://effectivehealthcare.ahrq.gov/products/health-data-mapping/report
Published Online: March 1, 2021
1
Technical Brief Disposition of Comments…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
October 08, 2025 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low
19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate
22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA
Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire
Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR
Toth, 2012 None Low NPP Diabetic
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - Obesity
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 10: Obesity
Potential High Impact Interventions Report
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockvill…
-
effectivehealthcare.ahrq.gov/products/bariatric-surgery-outcomes-diabetes/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - phentermine-topiramate and could present an
opportunity to simplify treatment for patients who are both diabetic … randomized controlled trial, SCALE™ (Satiety and Clinical Adiposity-Liraglutide Evidence in Non-
diabetic … and Diabetic people).51 The trial includes more than 5,000 patients who are either
overweight (BMIs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
June 01, 2018 - Evidence-Summary-CER-206-Sodium-And-Potassium-Intake-Effects-On-Chronic-Disease-Outcomes-And-Risk
Comparative Effectiveness Review
Number 206
Sodium and Potassium Intake: Effects on
Chronic Disease Outcomes and Risks
Evidence Summary
Background and Objectives
Cardiovascular disease (CVD) and kidney
disease1 ar…